<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=24115"><dc:title>Mycoplasma arginini cellulitis, tenosynovitis, and arthritis in kidney transplant recipient, Slovenia, 2024</dc:title><dc:creator>Vivoda,	Tjaša	(Avtor)
	</dc:creator><dc:creator>Rojko,	Tereza	(Avtor)
	</dc:creator><dc:creator>Kokošar Ulčar,	Barbara	(Avtor)
	</dc:creator><dc:creator>Strašek Smrdel,	Katja	(Avtor)
	</dc:creator><dc:creator>Celar Šturm,	Andraž	(Avtor)
	</dc:creator><dc:creator>Keše,	Darja	(Avtor)
	</dc:creator><dc:creator>Triglav,	Tina	(Avtor)
	</dc:creator><dc:creator>Večerić-Haler,	Željka	(Avtor)
	</dc:creator><dc:subject>Mycoplasma arginini</dc:subject><dc:subject>Slovenia</dc:subject><dc:subject>arthritis</dc:subject><dc:subject>bacteria</dc:subject><dc:subject>cellulitis</dc:subject><dc:subject>immunocompromised</dc:subject><dc:subject>kidney transplant recipient</dc:subject><dc:subject>zoonoses</dc:subject><dc:description>Mycoplasma arginini is a bacterium primarily found in animals and is seldom reported in human infections. We identified M. arginini infection in a severely immunocompromised kidney transplant recipient in Slovenia. Clinicians should be aware of M. arginini's potential as a pathogen in immunocompromised persons with animal contact.</dc:description><dc:date>2025</dc:date><dc:date>2025-11-13 11:09:15</dc:date><dc:type>Neznano</dc:type><dc:identifier>24115</dc:identifier><dc:language>sl</dc:language><dc:rights>Licenca Creative Commons je navedena na spletni strani založnika (https://wwwnc.cdc.gov/eid/about/general): Emerging Infectious Diseases is an open access journal published by the Centers for Disease Control and Prevention, a U.S. Government agency. Because the journal is in the public domain, its usage policy also conforms to conditions set forth by Creative Commons (https://creativecommons.org/licenses/by/4.0/).</dc:rights></rdf:Description></rdf:RDF>
